Genetic Variants in DNA Repair Pathways as Potential Biomarkers in Predicting Treatment Outcome of Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: A Systematic Review

Emma C. Hulshof, Lifani Lim, Ignace H. J. T. de Hingh, Hans Gelderblom, Henk-Jan Guchelaar, Maarten J. Deenen*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Article number577968
Number of pages11
JournalFrontiers in Pharmacology
Volume11
DOIs
Publication statusPublished - 6 Oct 2020

Keywords

  • biomarker
  • colorectal cancer
  • DNA repair
  • hyperthermic intraperitoneal chemotherapy
  • mitomycin C
  • oxaliplatin
  • treatment outcome
  • OXALIPLATIN-BASED CHEMOTHERAPY
  • COMPLETE CYTOREDUCTIVE SURGERY
  • SINGLE NUCLEOTIDE POLYMORPHISMS
  • STRAND BREAK REPAIR
  • CANCER PATIENTS
  • FOLFOX-4 TREATMENT
  • ASIAN PATIENTS
  • ERCC1
  • CARCINOMATOSIS
  • EXPRESSION

Cite this